Insider Trading activities of Gilead Sciences Inc insiders. , Part 4

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Gilead Sciences Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Gilead Sciences Inc since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Gilead Sciences Inc since 2005. The reporting company's ticker symbol is GILD. The reporting company's CIK number is 882095.
The total value of stock buying since 2005 is $2,912,783.
The total value of stock sales since 2005 is $2,341,165,981.
The total value of stock option exercises since 2005 is $444,271,390.



Table 2. Detailed insider stock purchases, sales, and option exercises of Gilead Sciences Inc insiders (GILD) , Part 4
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2014-02-28 Washington Robin L (EVP, CFO) Option Ex 30,600 23.01 704,106
2014-02-26 Moore Nicholas G Sale 20,000 84.05 1,681,080
2014-02-26 Moore Nicholas G Option Ex 20,000 26.61 532,300
2014-02-21 Washington Robin L (EVP, CFO) Sale 5,000 83.24 416,220
2014-02-21 Washington Robin L (EVP, CFO) Option Ex 5,000 23.60 118,000
2014-02-19 Washington Robin L (EVP, CFO) Sale 968 83.36 80,692
2014-02-19 Moore Nicholas G Sale 19,068 83.20 1,586,438
2014-02-19 Moore Nicholas G Option Ex 19,068 22.02 419,782
2014-02-14 Bischofberger Norbert W (EVP, R&D and CSO) Sale 90,000 81.97 7,377,030
2014-02-14 Bischofberger Norbert W (EVP, R&D and CSO) Option Ex 90,000 14.50 1,305,270
2014-02-10 Carter Paul Rutherford (EVP Commercial Ops) Sale 16,728 79.10 1,323,201
2014-02-10 Carter Paul Rutherford (EVP Commercial Ops) Option Ex 16,728 21.57 360,906
2014-02-03 Alton Gregg H (EVP, Corp & Med Affairs) Sale 33,000 80.28 2,649,273
2014-02-03 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 31,000 21.57 668,825
2014-02-03 Martin John C (Chairman and CEO) Sale 140,625 80.56 11,329,453
2014-02-03 Martin John C (Chairman and CEO) Option Ex 140,625 8.01 1,125,703
2014-01-23 Young Kevin (EVP, Commercial Operations) Sale 100,000 81.44 8,144,199
2014-01-23 Young Kevin (EVP, Commercial Operations) Option Ex 100,000 16.39 1,639,500
2014-01-21 Alton Gregg H (EVP, Corp & Med Affairs) Sale 120,000 80.00 9,600,000
2014-01-21 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 120,000 20.48 2,457,000
2014-01-14 Bischofberger Norbert W (EVP, R&D and CSO) Sale 90,000 74.34 6,690,870
2014-01-14 Bischofberger Norbert W (EVP, R&D and CSO) Option Ex 90,000 14.50 1,305,270
2014-01-02 Alton Gregg H (EVP, Corp & Med Affairs) Sale 113,000 75.17 8,493,984
2014-01-02 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 111,000 19.23 2,134,530
2014-01-02 Washington Robin L (SVP, CFO) Sale 35,600 75.03 2,671,210
2014-01-02 Washington Robin L (SVP, CFO) Option Ex 35,600 23.13 823,356
2014-01-02 Martin John C (Chairman and CEO) Sale 140,625 75.02 10,550,250
2014-01-02 Martin John C (Chairman and CEO) Option Ex 140,625 8.01 1,125,703
2013-12-20 Young Kevin (EVP, Commercial Operations) Sale 75,000 74.19 5,564,475
2013-12-20 Young Kevin (EVP, Commercial Operations) Option Ex 75,000 16.39 1,229,625
2013-12-16 Bischofberger Norbert W (EVP, R&D and CSO) Sale 90,000 71.75 6,457,950
2013-12-16 Bischofberger Norbert W (EVP, R&D and CSO) Option Ex 90,000 14.50 1,305,270
2013-12-02 Alton Gregg H (EVP, Corp & Med Affairs) Sale 30,000 74.47 2,234,070
2013-12-02 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 26,000 19.09 496,210
2013-12-02 Martin John C (Chairman and CEO) Sale 282,242 74.51 21,029,286
2013-12-02 Martin John C (Chairman and CEO) Option Ex 282,242 7.63 2,154,353
2013-12-01 Wilson Gayle E Option Ex 2,086 .00 0
2013-11-25 Milligan John F (President and COO) Option Ex 25,588 7.82 200,072
2013-11-22 Young Kevin (EVP, Commercial Operations) Sale 75,000 74.33 5,575,124
2013-11-22 Young Kevin (EVP, Commercial Operations) Option Ex 75,000 16.39 1,229,625
2013-11-21 Davignon Etienne Sale 9,778 71.57 699,791
2013-11-21 Milligan John F (President and COO) Sale 395,634 71.57 28,316,316
2013-11-21 Milligan John F (President and COO) Option Ex 395,634 7.63 3,019,874
2013-11-14 Milligan John F (President and COO) Sale 395,635 68.86 27,243,030
2013-11-14 Milligan John F (President and COO) Option Ex 395,635 7.63 3,019,881
2013-11-14 Bischofberger Norbert W (EVP, R&D and CSO) Sale 90,000 68.86 6,197,309
2013-11-14 Bischofberger Norbert W (EVP, R&D and CSO) Option Ex 90,000 14.50 1,305,270
2013-11-07 Milligan John F (President and COO) Sale 395,635 67.58 26,735,035
2013-11-07 Milligan John F (President and COO) Option Ex 395,635 7.63 3,019,881
2013-11-06 Washington Robin L (SVP, CFO) Sale 2,869 69.03 198,044
2013-11-05 Washington Robin L (SVP, CFO) Option Ex 6,000 .00 0
2013-11-01 Alton Gregg H (EVP, Corp & Med Affairs) Sale 30,000 70.79 2,123,730
2013-11-01 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 26,000 19.09 496,210
2013-11-01 Martin John C (Chairman and CEO) Sale 282,242 70.83 19,990,354
2013-11-01 Martin John C (Chairman and CEO) Option Ex 282,242 7.63 2,154,353
2013-10-23 Young Kevin (EVP, Commercial Operations) Sale 75,000 68.87 5,165,025
2013-10-23 Young Kevin (EVP, Commercial Operations) Option Ex 75,000 16.39 1,229,625
2013-10-14 Bischofberger Norbert W (EVP, R&D and CSO) Sale 90,000 62.84 5,655,960
2013-10-14 Bischofberger Norbert W (EVP, R&D and CSO) Option Ex 90,000 14.50 1,305,270
2013-10-01 Alton Gregg H (EVP, Corp & Med Affairs) Sale 30,000 62.75 1,882,560
2013-10-01 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 26,000 17.74 461,239
2013-10-01 Martin John C (Chairman and CEO) Sale 282,242 62.70 17,696,573
2013-10-01 Martin John C (Chairman and CEO) Option Ex 282,242 7.63 2,154,353
2013-09-30 Washington Robin L (SVP, CFO) Sale 35,600 63.20 2,249,920
2013-09-30 Washington Robin L (SVP, CFO) Option Ex 35,600 23.13 823,356
2013-09-23 Young Kevin (EVP, Commercial Operations) Sale 100,000 62.94 6,294,400
2013-09-23 Young Kevin (EVP, Commercial Operations) Option Ex 100,000 12.20 1,220,000
2013-09-16 Bischofberger Norbert W (EVP, R&D and CSO) Sale 90,000 63.49 5,714,010
2013-09-16 Bischofberger Norbert W (EVP, R&D and CSO) Option Ex 90,000 14.50 1,305,270
2013-09-03 Alton Gregg H (EVP, Corp & Med Affairs) Sale 30,000 61.24 1,837,350
2013-09-03 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 26,000 16.39 426,270
2013-09-03 Martin John C (Chairman and CEO) Sale 282,242 61.20 17,272,645
2013-09-03 Martin John C (Chairman and CEO) Option Ex 282,242 7.63 2,154,353
2013-08-30 Moore Nicholas G Sale 151,720 60.71 9,210,617
2013-08-30 Moore Nicholas G Option Ex 151,720 20.17 3,059,737
2013-08-14 Bischofberger Norbert W (EVP, R&D and CSO) Sale 90,000 59.00 5,309,730
2013-08-14 Bischofberger Norbert W (EVP, R&D and CSO) Option Ex 90,000 14.50 1,305,270
2013-08-02 Cogan John Francis Sale 17,000 61.51 1,045,636
2013-08-02 Cogan John Francis Option Ex 17,000 10.99 186,881
2013-08-01 Alton Gregg H (EVP, Corp & Med Affairs) Sale 30,000 61.76 1,852,890
2013-08-01 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 26,000 16.39 426,270
2013-08-01 Martin John C (Chairman and CEO) Sale 282,242 61.79 17,440,862
2013-08-01 Martin John C (Chairman and CEO) Option Ex 282,242 7.63 2,154,353
2013-07-30 Madigan John W Sale 249,000 61.97 15,430,779
2013-07-30 Madigan John W Option Ex 249,000 13.89 3,458,859
2013-07-15 Bischofberger Norbert W (EVP, R&D and CSO) Sale 90,000 57.34 5,160,150
2013-07-15 Bischofberger Norbert W (EVP, R&D and CSO) Option Ex 90,000 14.50 1,305,270
2013-07-02 Cogan John Francis Sale 17,000 51.66 878,288
2013-07-02 Cogan John Francis Option Ex 17,000 10.99 186,881
2013-07-01 Alton Gregg H (EVP, Corp & Med Affairs) Sale 30,000 52.35 1,570,470
2013-07-01 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 26,000 16.39 426,270
2013-07-01 Washington Robin L (SVP, CFO) Sale 45,600 52.31 2,385,427
2013-07-01 Washington Robin L (SVP, CFO) Option Ex 45,600 23.79 1,084,596
2013-07-01 Martin John C (Chairman and CEO) Sale 282,242 52.30 14,759,845
2013-07-01 Martin John C (Chairman and CEO) Option Ex 282,242 7.63 2,154,353
2013-06-07 Cogan John Francis Sale 110,000 52.15 5,736,940
2013-06-07 Cogan John Francis Option Ex 110,000 10.99 1,209,230
2013-06-03 Alton Gregg H (EVP, Corp & Med Affairs) Sale 30,000 52.96 1,588,860
2013-06-03 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 26,000 16.39 426,270
2013-06-03 Martin John C (Chairman and CEO) Sale 282,242 53.32 15,049,990
2013-06-03 Martin John C (Chairman and CEO) Option Ex 282,242 7.63 2,154,353
2013-05-10 Lofton Kevin E Option Ex 5,852 .00 0
2013-05-10 Whitley Richard James Option Ex 5,852 .00 0
2013-05-10 Cogan John Francis Option Ex 5,852 .00 0
2013-05-10 Wilson Gayle E Option Ex 5,852 .00 0
2013-05-10 Davignon Etienne Option Ex 5,852 .00 0
2013-05-10 Hills Carla A Option Ex 5,852 .00 0
2013-05-10 Wold Olsen Per Option Ex 5,852 .00 0
2013-05-10 Madigan John W Option Ex 5,852 .00 0
2013-05-01 Alton Gregg H (EVP, Corp & Med Affairs) Sale 30,000 50.20 1,506,120
2013-05-01 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 26,000 16.39 426,270
2013-05-01 Martin John C (Chairman and CEO) Sale 282,242 50.17 14,160,927
2013-05-01 Martin John C (Chairman and CEO) Option Ex 282,242 7.63 2,154,353
2013-04-11 Washington Robin L (SVP, CFO) Sale 968 50.20 48,593
2013-04-01 Alton Gregg H (EVP, Corp & Med Affairs) Sale 30,000 48.67 1,460,010
2013-04-01 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 26,000 16.39 426,270
2013-04-01 Washington Robin L (SVP, CFO) Sale 13,000 48.23 626,951
2013-04-01 Washington Robin L (SVP, CFO) Option Ex 13,000 25.99 337,844
2013-04-01 Martin John C (Chairman and CEO) Sale 282,242 48.24 13,615,071
2013-04-01 Martin John C (Chairman and CEO) Option Ex 282,242 7.63 2,154,353
2013-03-27 Washington Robin L (SVP, CFO) Sale 45,000 47.07 2,118,150
2013-03-27 Washington Robin L (SVP, CFO) Option Ex 45,000 27.07 1,218,150
2013-03-14 Washington Robin L (SVP, CFO) Sale 4,304 45.85 197,321
2013-03-05 Washington Robin L (SVP, CFO) Sale 45,000 44.41 1,998,449
2013-03-05 Washington Robin L (SVP, CFO) Option Ex 45,000 24.30 1,093,275
2013-03-04 Washington Robin L (SVP, CFO) Sale 9,800 43.68 428,044
2013-03-04 Washington Robin L (SVP, CFO) Option Ex 9,800 23.68 232,034
2013-03-01 Alton Gregg H (EVP, Corp & Med Affairs) Sale 30,000 43.25 1,297,470
2013-03-01 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 26,000 16.39 426,270
2013-03-01 Moore Nicholas G Option Ex 167 .00 0
2013-03-01 Martin John C (Chairman and CEO) Sale 282,242 43.24 12,203,579
2013-03-01 Martin John C (Chairman and CEO) Option Ex 282,242 7.63 2,154,353
2013-02-28 Wold Olsen Per Buy 10,000 43.05 430,490
2013-01-28 Washington Robin L (SVP, CFO) Sale 11,550 39.48 456,028
2013-01-28 Washington Robin L (SVP, CFO) Option Ex 11,550 19.09 220,431
2013-01-02 Alton Gregg H (EVP, Corp & Med Affairs) Sale 115,000 74.67 8,587,625
2013-01-02 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 113,000 29.98 3,387,175
2013-01-02 Martin John C (Chairman and CEO) Sale 141,121 74.50 10,514,220
2013-01-02 Martin John C (Chairman and CEO) Option Ex 141,121 15.27 2,154,212
2012-12-10 Martin John C (Chairman and CEO) Option Ex 12,794 15.64 200,059
2012-12-03 Alton Gregg H (EVP, Corp & Med Affairs) Sale 22,000 75.34 1,657,458
2012-12-03 Alton Gregg H (EVP, Corp & Med Affairs) Option Ex 21,000 29.00 609,105
2012-12-03 Martin John C (Chairman and CEO) Sale 145,500 75.04 10,917,883
2012-12-03 Martin John C (Chairman and CEO) Option Ex 145,500 8.94 1,301,206
2012-12-01 Wilson Gayle E Option Ex 3,131 .00 0
2012-11-30 Moore Nicholas G Sale 65,000 74.96 4,872,530
2012-11-30 Moore Nicholas G Option Ex 65,000 28.68 1,863,875
2012-11-28 Denny James M Sale 20,000 73.91 1,478,220
2012-11-28 Denny James M Option Ex 64,000 24.05 1,539,520
2012-11-19 Young Kevin (EVP, Commercial Operations) Sale 360,000 74.31 26,751,240

Insider trading activities including stock purchases, stock sales, and option exercises of GILD listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Gilead Sciences Inc (symbol GILD, CIK number 882095) see the Securities and Exchange Commission (SEC) website.